bromohydrin-pyrophosphate and Kidney-Neoplasms

bromohydrin-pyrophosphate has been researched along with Kidney-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for bromohydrin-pyrophosphate and Kidney-Neoplasms

ArticleYear
Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
    Journal of immunotherapy (Hagerstown, Md. : 1997), 2008, Volume: 31, Issue:3

    We previously showed that Vdelta2 T cells infiltrate renal tumors and can be expanded as potent cytotoxic effectors from peripheral blood mononuclear cells of most renal cell carcinoma (RCC) patients, using a structural analog of nonconventional T-cell receptor gamma9delta2 ligand, bromohydrin pyrophosphate, and interleukin-2 (IL-2). In this study, we have further investigated the differentiation status and the migration potential of circulating and tumor-infiltrating Vgamma9Vdelta2 T lymphocytes from RCC patients. The repertoire of tumor-infiltrating and peripheral Vgamma9Vdelta2 T cells from RCC patients was characterized by a dominant CD27- CD45RA- subset. These effector memory Vgamma9Vdelta2 T cells were efficiently expanded using bromohydrin pyrophosphate combined with IL-15, but not IL-2. In addition, peripheral Vgamma9Vdelta2 T cells from RCC patients present a modified chemotactic pattern compared with donors. After ex vivo activation, peripheral expanded Vgamma9Vdelta2 T cells acquire low-migration capacities toward renal cells. Tumor-infiltrating Vgamma9Vdelta2 T cells migrated with higher efficiency toward primary renal tumor cells. The traffic toward tumor cells required the CXCL12/CXCR4 interaction. Altogether, these results outline that those Vgamma9Vdelta2 effectors exhibit differential migration capacities according to their localization, their differentiation status, and the tumor microenvironment parameters that may influence their use in immunotherapy.

    Topics: Carcinoma, Renal Cell; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Chemotaxis, Leukocyte; Diphosphates; Gene Expression Profiling; Humans; Immunologic Memory; Interleukin-15; Kidney Neoplasms; Lymphocyte Activation; Lymphocyte Subsets; Lymphocytes, Tumor-Infiltrating; Protein Array Analysis; Receptors, Antigen, T-Cell, gamma-delta; Receptors, Chemokine; Receptors, CXCR4; T-Lymphocytes

2008
Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
    Journal of immunology (Baltimore, Md. : 1950), 2005, Feb-01, Volume: 174, Issue:3

    Metastatic renal cell carcinoma, inherently resistant to conventional treatments, is considered immunogenic. Indeed, partial responses are obtained after treatment with cytokines such as IL-2 or IFN-alpha, suggesting that the immune system may control the tumor growth. In this study, we have investigated the ability of the main subset of peripheral gammadelta lymphocytes, the Vgamma9Vdelta2-TCR T lymphocytes, to induce an effective cytotoxic response against autologous primary renal cell carcinoma lines. These gammadelta T cells were expanded ex vivo using a Vgamma9Vdelta2 agonist, a synthetic phosphoantigen called Phosphostim. From 11 of 15 patients, the peripheral Vgamma9Vdelta2 T cells were amplified in vitro by stimulating PBMCs with IL-2 and Phosphostim molecule. These expanded Vgamma9Vdelta2 T cells express activation markers and exhibit an effector/memory phenotype. They display a selective lytic potential toward autologous primary renal tumor cells and not against renal NC. The lytic activity involves the perforin-granzyme pathway and is mainly TCR and NKG2D receptor dependent. Furthermore, an increased expression of MHC class I-related molecule A or B proteins, known ligands of NKG2D, are detected on primary renal tumor cells. Interestingly, from 2 of the 11 positive cultures in response to Phosphostim, expanded-Vgamma9Vdelta2 T cells present an expression of killer cell Ig-like receptors, suggesting their prior recruitment in vivo. Unexpectedly, on serial frozen sections from three tumors, we observe a gammadelta lymphocyte infiltrate that was mainly composed of Vgamma9Vdelta2 T cells. These results outline that Vgamma9Vdelta2-TCR effectors may represent a promising approach for the treatment of metastatic renal cell carcinoma.

    Topics: Adult; Aged; Aged, 80 and over; Antigens; Carcinoma, Renal Cell; Cell Differentiation; Cell Line, Tumor; Cytotoxicity, Immunologic; Diphosphates; Female; Humans; Immunophenotyping; Kidney Neoplasms; Killer Cells, Natural; Leukocytes, Mononuclear; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; NK Cell Lectin-Like Receptor Subfamily K; Receptors, Antigen, T-Cell, gamma-delta; Receptors, Immunologic; Receptors, KIR; Receptors, Natural Killer Cell; T-Lymphocyte Subsets

2005